Gubra A S (GUBRF) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Gubra A/s.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.179 Welcome to today's event with Gubra, and the focus for today's event will 00:00:05.179 -- 00:00:10.267 of course be the cancelled half-year contract that came earlier this morning, but also 00:00:10.267 -- 00:00:15.515 the adjustment to Outlook for 2025, which came last night. 00:00:15.515 -- 00:00:20.983 And from Gubra, as always, the CEO Henrik Blau and CFO Christian 00:00:20.983 -- 00:00:25.765 Borbos are also participating, and he will come into the picture when he will present. 00:00:25.765 -- 00:00:30.231 As always, this event will of course be recorded, and when we have edited the event, 00:00:30.231 -- 00:00:35.358 we will share it on our platform, and I'm sure Goob will also like to do it 00:00:35.358 -- 00:00:40.665 on theirs. And as usual, I would like to welcome all investors to this event, 00:00:40.665 -- 00:00:44.770 and as always, if you have any questions, then ask the questions, and I will give them 00:00:44.770 -- 00:00:49.877 to Henrik and Christian afterwards. So with that said, I would like to welcome you, 00:00:49.877 -- 00:00:52.360 Henrik, and take care. 00:00:52.360 -- 00:00:58.125 Thank you, Klaus, and also from my side, welcome to those who are listening today. 00:00:58.125 -- 00:01:03.009 We have had the pleasure of presenting the results from the first half of this year, 00:01:03.009 -- 00:01:08.154 and we have, as usual, taken some slides with us. 00:01:08.154 -- 00:01:10.295 First of all, quite briefly, who is Gubber? 00:01:10.295 -- 00:01:13.398 Well, we are experts in metabolic diseases. 00:01:13.398 -- 00:01:17.481 We have a lot of focus on birth and overweight, 00:01:17.481 -- 00:01:22.128 but also on other diseases related to metabolism. 00:01:22.128 -- 00:01:27.376 We have a hybrid business mode...